As previously shown in the complete group of men and women with MDD from the Neuropharm trial, we here confirm that a lower cerebral 5-HT4R level is also observed in the male MDD population alone compared to healthy men (β = −0.07, p = 0.012). This evidence concerns the gene HTR4 and major depressive disorder.